Authors: OPAL SM FISHER CJ DHAINAUT JFA VINCENT JL BRASE R LOWRY SF SADOFF JC SLOTMAN GJ LEVY H BALK RA SHELLY MP PRIBBLE JP LABRECQUE JF LOOKABAUGH J DONOVAN H DUBIN H BAUGHMAN R NORMAN J DEMARIA E MATZEL K ABRAHAM E SENEFF M BARBER A BRAYMAN K CERRA F CHALFIN D CHAZEN G CHRISTOU N COONEY R CORBIN R DREW R EMMANUEL G PINES B ERON L FLETCHER R FOULKE G GALLAGHER T GERVICH D GROSSMAN J HALPERN N HANNA C JOHNSON S KUBAK B LODATO R LOVETT M MARSHALL J METZLER M NELSON L FREELAND M OROPELLO J PAZ H RACKOW E RIKER R RISSING P SCHEIN R SCHELD M SCHUSTER D SIBBALD W SILVERMAN H SOMERMEYER M STRANGE C SUMMER W TOPIEL M WHITE J ALESTIG K ANDERSEN PK ANDERSSON J BENNETT D BERG S BLEICHNER G BRUNET F CARLET J DEJONG MJ DREXLER H GARRARD C HESLET L KLOSS T PAUL W REINHART K RENAUD B RITZ R ROMME JH SCHMITZ JE STOCKENHUBER F SUTER P TENAILLON A VAGT A VANDERMEER WM VANDEVENTER S VANLEEUWEN PAM VERHOEF J WEBSTER N WINTER RJ WOLFF M STILES DM DEVOS A CROFT C FAZIO J THOMPSON R WIEDEMANN H ELLISON RT CHINCHILLI VM YARBOROUGH M

Citation: Sm. Opal et al., CONFIRMATORY INTERLEUKIN-1 RECEPTOR ANTAGONIST TRIAL IN SEVERE SEPSIS- A PHASE-III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER TRIAL, Critical care medicine, 25(7), 1997, pp. 1115-1124

Authors: DANIS M DEVITA M BAILY MA BEYDA D CHALFIN D DAGI F DAVILA F ENGLEHARDT T GRENVIK A HOFMANN P HOYT J JAMETON A KELLY DF KOCH K LANGE MP PARK A LO B LYNN J MARSHALL MF MCCARTNEY J NELSON RM PARKS L RADOVICH P REARDON F RIE M ROSENBAUM S ROTHENBERG D SILVERMAN H SOTTILE F SPANIER A SPRUNG CL STEINBERG A STEINHORN D STOLTZFUS D TENDLER RM TERES D TRUOG R WALLACE TE WLODY G YEH T

Citation: M. Danis et al., CONSENSUS STATEMENT OF THE SOCIETY-OF-CRITICAL-CARE-MEDICINE ETHICS-COMMITTEE REGARDING FUTILE AND OTHER POSSIBLY INADVISABLE TREATMENTS, Critical care medicine, 25(5), 1997, pp. 887-891

Authors: BONE RC BALK RA FEIN AM PERL TM WENZEL RP REINES HD QUENZER RW IBERTI TJ MACINTYRE N SCHEIN RMH TRENHOLME G NIEDERMAN M CHALFIN D ABALOS A OROPELLO J EMPSON P CAMINITII S GREENMAN R BOOTH F PLOUFFE J RUSSELL J GIANAKOPOULOS G IANNINI P HINDES R COBLENS K KOHLER R MARTIN M BERNARD G EDWARDS J CRISLIP M FILLER S NASRAWAY SA SIGEL PK SOTTILE FD MARTIN DH DEBOISBLANC BP CHANDRASEKAR PH BROUGHTON WA MIDDLETON RM SEIBERT AF EMMANUEL G LIE TH ANDERSON CLV PANKEY GA ANDERSON P OLSEN K SANPEDRO GS GRAHAM D GROSSMAN J WELS PB SCHENTAG J BIRMINGHAM MC MCGRATH B TUAZON C CONRY K BELLO E MCCUE JM ELLRODT G STEIN S RIEDINGER M CHMEL H TONEY J YANGCO B RACKOW E ASTIZ ME CARPATI C JACOBS R HOLCROFT J BAGLEY M VASSAR MJ GOTTLIEB J KUBIS J CHAMBERS H LIEBLER J BROWN A MCCAFFREE R WEDEL N HANNIGAN J NELSON BJ SARIA EA JONES H ACKERMAN S SCANNON P WEBB CD

Citation: Rc. Bone et al., A 2ND LARGE CONTROLLED CLINICAL-STUDY OF E5, A MONOCLONAL-ANTIBODY TOENDOTOXIN - RESULTS OF A PROSPECTIVE, MULTICENTER, RANDOMIZED, CONTROLLED TRIAL, Critical care medicine, 23(6), 1995, pp. 994-1006

Authors: AUGUSTINE G FLASTER E FEIN AM NIEDERMAN MS SCOTT W CHALFIN D

Citation: G. Augustine et al., COPD INCREASES RESPIRATORY COMPLICATIONS BUT NOT MORTALITY IN PATIENTS UNDERGOING CORONARY-BYPASS SURGERY (CABG), The American review of respiratory disease, 147(4), 1993, pp. 323-323